ConductScience.org, home

Paper8097925

Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.

Omvik P and 2 others. Cardiovasc Drugs Ther, 1993. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure. Papers, record 8097925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8097925

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
PubMed
Journal
Cardiovasc Drugs Ther
PubMed
Year
1993
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.22
iCite
Revised in PubMed
2019-09-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Omvik PP
2Lund-Johansen PP
3Haugland HH

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AgonistsMajor topic
Adrenergic beta-AntagonistsMajor topic
Antihypertensive AgentsMajor topic
AtenololMajor topic
BenzeneacetamidesMajor topic
Blood PressureMajor topic
ExerciseMajor topic
PropanolaminesMajor topic
RestMajor topic
Adult
Double-Blind Method
Drug Administration Schedule
Heart Rate
Humans
Male
Middle Aged
Posture
Stroke Volume

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12454357Circadian antihypertensive profile of carvedilol (BM 14190).J Cardiovasc Pharmacol1987https://conductscience.org/library/papers/2454357PubMed
26134820Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.J Pharmacol Exp Ther1983https://conductscience.org/library/papers/6134820PubMed
36151777Physical performance and muscle metabolism during beta-adrenergic blockade in man.Acta Physiol Scand Suppl1984https://conductscience.org/library/papers/6151777PubMed
4973971Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.Br J Clin Pharmacol1976https://conductscience.org/library/papers/973971PubMed
55021493Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.Am J Cardiol1972https://conductscience.org/library/papers/5021493PubMed
66137366Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.Eur Heart J1983https://conductscience.org/library/papers/6137366PubMed
75640885The paradox of beta-adrenergic blockade in hypertension.Circulation1968https://conductscience.org/library/papers/5640885PubMed
86125175How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125175PubMed
91678963
Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
Cardiovasc Drugs Ther1991https://conductscience.org/library/papers/1678963PubMed
102880663Comparison of the immediate effects of two beta-blocking drugs: a nonselective and a cardioselective with modest ISA in exercise-induced angina.Cardiology1987https://conductscience.org/library/papers/2880663PubMed
116144632Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents.Hypertension1984https://conductscience.org/library/papers/6144632PubMed
121964580The initial hemodynamic response to newer antihypertensive agents at rest and during exercise: review of visacor, doxazosin, nisoldipine, tiapamil, perindoprilat, pinacidil, dilevalol, and carvedilol.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/1964580PubMed
131860471Acute haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.Eur Heart J1991https://conductscience.org/library/papers/1860471PubMed
146152175Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6152175PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
8395198
Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8395198PubMed
8103354Do partial agonist beta-blockers have improved clinical utility?Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8103354PubMed
7918133Acute systemic and antiischemic effects of epanolol in patients with coronary artery disease.Cardiovasc Drugs Ther1994https://conductscience.org/library/papers/7918133PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8097925

GET https://conductscience.org/api/papers/v1/8097925/authors